LCA5 and Leber congenital amaurosis: Together, these results show the importance of a precise and controlled spatiotemporal expression of lebercilin to improve gene therapy efficacy for LCA, which already showed interesting functional results, including partial restoration of electroretinograms, amelioration of pupillary light responses, and improved functional vision (23, 24).